Investment type
Equity / Class A Common Stock
Latest Disclosed Shares Owned
6,300,000 shares
Security Ownership %
6.5%

SymBiosis Capital Partners, LLC ownership in Rani Therapeutics Holdings, Inc. Class A Common Stock

12 Feb 2026 - SymBiosis Capital Partners, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,300,000 shares of Rani Therapeutics Holdings, Inc. Class A Common Stock. This represents 6.5% ownership of the company. This is the first filing by SymBiosis Capital Partners, LLC disclosing ownership of Rani Therapeutics Holdings, Inc. Class A Common Stock.